title: Promotion of survival and differentiation of neural stem cells with fibrin and growth factor cocktails after severe spinal cord injury.
abstract: Neural stem cells (NSCs) can self-renew and differentiate into neurons and glia. Transplanted NSCs can replace lost neurons and glia after spinal cord injury (SCI), and can form functional relays to re-connect spinal cord segments above and below a lesion. Previous studies grafting neural stem cells have been limited by incomplete graft survival within the spinal cord lesion cavity. Further, tracking of graft cell survival, differentiation, and process extension had not been optimized. Finally, in previous studies, cultured rat NSCs were typically reported to differentiate into glia when grafted to the injured spinal cord, rather than neurons, unless fate was driven to a specific cell type. To address these issues, we developed new methods to improve the survival, integration and differentiation of NSCs to sites of even severe SCI. NSCs were freshly isolated from embryonic day 14 spinal cord (E14) from a stable transgenic Fischer 344 rat line expressing green fluorescent protein (GFP) and were embedded into a fibrin matrix containing growth factors; this formulation aimed to retain grafted cells in the lesion cavity and support cell survival. NSCs in the fibrin/growth factor cocktail were implanted two weeks after thoracic level-3 (T3) complete spinal cord transections, thereby avoiding peak periods of inflammation. Resulting grafts completely filled the lesion cavity and differentiated into both neurons, which extended axons into the host spinal cord over remarkably long distances, and glia. Grafts of cultured human NSCs expressing GFP resulted in similar findings. Thus, methods are defined for improving neural stem cell grafting, survival and analysis of in vivo findings.
authors.affiliation: Veterans Administration Medical Center, San Diego; Department of Neurosciences, University of California, San Diego; plu@ucsd.edu.
authors.forename: Paul
authors.initials: P
authors.lastname: Lu
authors.affiliation: Department of Neurosciences, University of California, San Diego.
authors.forename: Lori
authors.initials: L
authors.lastname: Graham
authors.affiliation: Department of Neurosciences, University of California, San Diego.
authors.forename: Yaozhi
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Department of Neurosciences, University of California, San Diego.
authors.forename: Di
authors.initials: D
authors.lastname: Wu
authors.affiliation: Veterans Administration Medical Center, San Diego; Department of Neurosciences, University of California, San Diego.
authors.forename: Mark
authors.initials: M
authors.lastname: Tuszynski
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D005337:Fibrin / Q000494:pharmacology*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology*; D008297:Male; D058953:Neural Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000637:transplantation*; D051381:Rats; D011916:Rats, Inbred F344; D055647:Rats, Transgenic; D013119:Spinal Cord Injuries / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods*
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; D005337:Fibrin